Marcos Cortes

CDMO Platforms Will Be The Central Arena For MedTech M&A In 2026

The Inflation Reduction Act: Is It Good Or Bad For Drug Innovation?

M&A After The FTC's Non-Compete Ban: Can Garden Leave Structures Fill The Gap?

A&M CTG's Insight-Oriented Approach (Video)

A&M CTG's Insight-Oriented Approach Will Disrupt M&A Industry Norms